These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2324554)

  • 21. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
    Akira S; Kishimoto T
    Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S
    J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130).
    Geisterfer M; Richards CD; Gauldie J
    Cytokine; 1995 Aug; 7(6):503-9. PubMed ID: 8580365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
    Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
    Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptors for interleukin 4, interleukin 5 and interleukin 6.
    Banchereau J; Galizzi JP
    Ann Ist Super Sanita; 1990; 26(3-4):453-67. PubMed ID: 2091506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
    Hirano T; Ishihara K; Hibi M
    Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gp130 signaling.
    Zhang P; Chebath J; Lonai P; Revel M
    Stem Cells; 2004; 22(3):344-54. PubMed ID: 15153611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition.
    Scheller J; Kovaleva M; Rabe B; Eichler J; Kallen KJ; Rose-John S
    J Immunol Methods; 2004 Aug; 291(1-2):93-100. PubMed ID: 15345308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).
    Akira S; Hirano T; Taga T; Kishimoto T
    FASEB J; 1990 Aug; 4(11):2860-7. PubMed ID: 2199284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of a two-chain IL-6 receptor system in immune and hematopoietic cell regulation.
    Taga T; Kishimoto T
    Crit Rev Immunol; 1992; 11(5):265-80. PubMed ID: 1642780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interleukin 6 (IL-6)].
    Dohi K; Iwano M; Horii Y
    Nihon Rinsho; 1992 Dec; 50(12):2916-20. PubMed ID: 1491446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cloning and expression of an IL-6 signal transducer, gp130.
    Hibi M; Murakami M; Saito M; Hirano T; Taga T; Kishimoto T
    Cell; 1990 Dec; 63(6):1149-57. PubMed ID: 2261637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diseases associated with cytokine dysregulation].
    Kishimoto T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):724-34. PubMed ID: 8371004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular biology of interleukin 6 and its receptor.
    Kishimoto T; Hibi M; Murakami M; Narazaki M; Saito M; Taga T
    Ciba Found Symp; 1992; 167():5-16; discussion 16-23. PubMed ID: 1425018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 and its relation to inflammation and disease.
    Hirano T
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S60-5. PubMed ID: 1728989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.
    Schirmacher P; Peters M; Ciliberto G; Blessing M; Lotz J; Meyer zum Büschenfelde KH; Rose-John S
    Am J Pathol; 1998 Aug; 153(2):639-48. PubMed ID: 9708822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6 and its receptor in autoimmunity.
    Kishimoto T
    J Autoimmun; 1992 Apr; 5 Suppl A():123-32. PubMed ID: 1380241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.